These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22585436)

  • 1. Mitochondrial dynamics: general concepts and clinical implications.
    Milone M; Benarroch EE
    Neurology; 2012 May; 78(20):1612-9. PubMed ID: 22585436
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous MFN2 and GDAP1 mutations cause major mitochondrial defects in a patient with CMT.
    Cassereau J; Casasnovas C; Gueguen N; Malinge MC; Guillet V; Reynier P; Bonneau D; Amati-Bonneau P; Banchs I; Volpini V; Procaccio V; Chevrollier A
    Neurology; 2011 Apr; 76(17):1524-6. PubMed ID: 21519004
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A.
    Cartoni R; Arnaud E; Médard JJ; Poirot O; Courvoisier DS; Chrast R; Martinou JC
    Brain; 2010 May; 133(Pt 5):1460-9. PubMed ID: 20418531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why size matters - balancing mitochondrial dynamics in Alzheimer's disease.
    DuBoff B; Feany M; Götz J
    Trends Neurosci; 2013 Jun; 36(6):325-35. PubMed ID: 23582339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutation of the mitofusin 2 gene in a family with Charcot-Marie-Tooth disease type 2.
    Bergamin G; Dalla Torre C; Cacciavillani M; Lucchetta M; Boaretto F; Campagnolo M; Mostacciuolo ML; Briani C
    Muscle Nerve; 2014 Jan; 49(1):145-6. PubMed ID: 23929728
    [No Abstract]   [Full Text] [Related]  

  • 6. Dysregulation of mitochondrial fusion and fission: an emerging concept in neurodegeneration.
    Frank S
    Acta Neuropathol; 2006 Feb; 111(2):93-100. PubMed ID: 16468021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A.
    Züchner S; Mersiyanova IV; Muglia M; Bissar-Tadmouri N; Rochelle J; Dadali EL; Zappia M; Nelis E; Patitucci A; Senderek J; Parman Y; Evgrafov O; Jonghe PD; Takahashi Y; Tsuji S; Pericak-Vance MA; Quattrone A; Battaloglu E; Polyakov AV; Timmerman V; Schröder JM; Vance JM
    Nat Genet; 2004 May; 36(5):449-51. PubMed ID: 15064763
    [No Abstract]   [Full Text] [Related]  

  • 8. A new gene for the Charcot-Marie-Tooth disorder.
    Ben-Asher E; Lancet D
    Isr Med Assoc J; 2004 Jun; 6(6):376-7. PubMed ID: 15214472
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.
    Cartoni R; Martinou JC
    Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives.
    Stuppia G; Rizzo F; Riboldi G; Del Bo R; Nizzardo M; Simone C; Comi GP; Bresolin N; Corti S
    J Neurol Sci; 2015 Sep; 356(1-2):7-18. PubMed ID: 26143526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial fusion protein mutated in CMT2A.
    Bradbury J
    Lancet Neurol; 2004 Jun; 3(6):326. PubMed ID: 15176403
    [No Abstract]   [Full Text] [Related]  

  • 12. Fifteen-year longitudinal follow-up of a patient with severe early-onset Charcot-Marie-Tooth disease type 2A.
    McCray BA; Hurst W; Crawford TO; Lloyd TE
    Muscle Nerve; 2018 May; 57(5):E126-E128. PubMed ID: 29266326
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitochondrial dynamics in mammalian health and disease.
    Liesa M; Palacín M; Zorzano A
    Physiol Rev; 2009 Jul; 89(3):799-845. PubMed ID: 19584314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal role of the low-molecular-weight neurofilament protein in mitochondrial dynamics and disruption in Charcot-Marie-Tooth disease.
    Gentil BJ; Minotti S; Beange M; Baloh RH; Julien JP; Durham HD
    FASEB J; 2012 Mar; 26(3):1194-203. PubMed ID: 22155564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MFN2 transcripts escaping from nonsense-mediated mRNA decay pathway cause Charcot-Marie-Tooth disease type 2A2.
    Kawarai T; Yamasaki K; Mori A; Takamatsu N; Osaki Y; Banzrai C; Miyamoto R; Oki R; Pedace L; Orlacchio A; Nodera H; Hashiguchi A; Higuchi Y; Takashima H; Nishida Y; Izumi Y; Kaji R
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1263-1265. PubMed ID: 27154191
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitochondrial dynamics in disease.
    Chan DC
    N Engl J Med; 2007 Apr; 356(17):1707-9. PubMed ID: 17460225
    [No Abstract]   [Full Text] [Related]  

  • 17. Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations.
    Zhu D; Kennerson ML; Walizada G; Züchner S; Vance JM; Nicholson GA
    Neurology; 2005 Aug; 65(3):496-7. PubMed ID: 16087932
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical, electrophysiological and pathological findings of a patient with CMT2 due to the p.Ala738Val mitofusin 2 mutation.
    Luigetti M; Fabrizi GM; Taioli F; Conte A; Del Grande A; Sabatelli M
    J Neurol Sci; 2011 Aug; 307(1-2):168-70. PubMed ID: 21601224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells.
    Santel A; Frank S; Gaume B; Herrler M; Youle RJ; Fuller MT
    J Cell Sci; 2003 Jul; 116(Pt 13):2763-74. PubMed ID: 12759376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity.
    Ishihara N; Eura Y; Mihara K
    J Cell Sci; 2004 Dec; 117(Pt 26):6535-46. PubMed ID: 15572413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.